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ABSTRACT 
The desire to increase the precision in radiotherapy delivery  has led to the development of advanced imaging 
systems such as amorphous silicon (a-Si)-based electronic portal imaging, and kV and MV cone beam CT. These are 
used prior to the delivery of radiation to visualise the organ to be treated and to ensure that the patient setup and 
treatment delivery are accurate. However, little attention has been given to the dose received by adjacent normal tissues 
during these imaging procedures. Though these doses are very small compared to the dose delivered during radiotherapy, 
the involvement of normal tissues and the concern that these could increase the probability of stochastic effect, mainly 
the induction of secondary malignancy, cannot be ignored. This article reviews some work on the doses received during 
imaging in radiotherapy and the methods to optimise the same. © 2007 Biomedical Imaging and Intervention Journal. 
All rights reserved. 
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INTRODUCTION 
Recent  technological  developments  have  instilled 
considerable  interest  in  advanced  radiotherapy 
techniques  such  as  Three  Dimensional  Conformal 
Radiotherapy  (3D-CRT)  and  Intensity  Modulated 
Radiotherapy  (IMRT).  These  techniques  have  enabled 
dose escalation to the clinical target volume (CTV) and 
dose  reduction  to  normal  tissues  as  well  as  to  the 
surrounding critical organs thus leading to better tumour 
control  probability  (TCP)  and  lower  normal  tissue 
complication probability (NTCP). The success of these 
techniques depends heavily on the accuracy in targeting 
the CTV, and achieving the aimed sparing of the normal 
tissues.  Conventionally, external markers made on the 
patient surface are used to direct the radiation beam to 
the target volume. This could result in geographical miss 
as the relationship between the external marker and the 
CTV  could  have  been  lost  during  the  time  between 
planning and the treatment, and during the course of the 
treatment. In order to achieve accurate targeting during 
treatment,  the  organ  to  be  treated  is  visualised  using 
portal imaging. Portal imaging is the use of a therapeutic 
X-ray or gamma ray beam to form an image of the area 
being irradiated and its main application is to analyse the 
patient  setup  during  treatment  and  account  for  the 
uncertainty in treatment delivery. It is well known that 
the  images  produced  with  Megavoltage  (MV)  beam 
suffer from low subject contrast compared to the images 
produced with kV X-ray beams. This is mainly due to the 
fact  that  the  MV  beams  interact  with  the  patient  by 
Compton  scattering  that  depends  on  the  density  rather 
than the atomic number. In addition to this, many other 
factors contribute to the poor quality of images in portal 
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imaging  and  these  include  the  performance  of  image 
receptor, scatter due to patient thickness, source size, etc. 
[1]. 
Portal  images  have  been  defined  as  three  types: 
localisation  radiograph,  verification  film  and  double 
exposure [2]. X-ray film is the traditional  medium  for 
portal  imaging.  Historically,  portal  imaging  has  been 
performed with industrial films [3] mainly for complex-
shaped beams such as the one used in Mantle Technique 
for  Hodgkin’s  disease.  A  few  centres  have  also  been 
using the Computed Radiography (CR) technology with 
the Photostimulable Phosphor Plate (PSP) for MV portal 
imaging in radiation therapy [4]. The main advantage of 
this  method  is  that  the  images  are  made  available  in 
digital  format.  Electronic  portal  imaging  (EPI)  was 
introduced  in  the  early  1980s  when  the  late  Norman 
Baily demonstrated the use of a fluoroscopic system to 
acquire MV transmission images. Since then electronic 
portal  imaging  devices  have  undergone  significant 
developments from CCD-based imaging devices to a-Si 
flat  panel  devices.  Electronic  portal  imaging  devices 
(EPID) have many potential advantages over traditional 
X-ray films for portal imaging. The images obtained are 
immediately available and can be used interactively to 
adjust patient or field position during radiotherapy. The 
digital  images  aid  image  processing,  contrast 
enhancement  and  image  matching.  Moreover,  digital 
archiving  saves  space  and  allows  for  rapid  recall  of 
images over a network [3]. These developments in portal 
imaging have resulted in the development of 3D imaging 
for positioning. 
The  advantage  of  obtaining  full  volumetric 
information with single rotation of the source and the flat 
panel  detector  with  cone  beam  CT  has  led  to  its 
introduction  as  an  image  guidance  system  in  radiation 
therapy. Cone beam CT generated with the MV beam is 
used  to  obtain  patient  setup  information  in  3D  by 
registering these images with the planning CT images in 
radiation therapy. A few vendors provide cone beam CT 
obtained with kV beam for setup verification. This has 
been made possible by having a kV X-ray tube and a flat 
panel detector 90
o to the treatment beam [5]. 
The requirement of radiation protection as per the 
international  basic  safety  standards  (BSS  115)  is  that 
“any medical exposure should be justified by weighing 
the  diagnostic  or  therapeutic  benefits  they  produce 
against  the  radiation  detriment  they  might  cause  by 
taking  into  account  the  benefits  and  risks  of  available 
alternative  techniques  that  do  not  involve  medical 
exposure”. In radiation therapy, it is generally assumed 
that  the  potential  of  radiation  dose  delivered  during 
imaging for verification and localisation does not add to 
the  patient’s  burden  because  the  doses  from  such 
exposures  are  very  small  compared  with  the  intended 
therapy dose.  This is true when considering imaging of 
the target volume that receives the intended prescribed 
dose.  However,  imaging  during  radiotherapy  for  setup 
verification  results  in  dose  exposure  to  normal  tissues 
outside  the  tumour  volume.  In  this  paper,  the  dose 
received  due  to  portal  imaging,  image  guidance 
techniques, such as MV and kV cone beam CT, and the 
methods that have been suggested to optimise the dose to 
            
(a)                                                                                     (b) 
Figure 1  (a) Single exposure port film obtained with Computed Radiography (CR) for 6 MV X-rays; (b) Double 
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normal  tissues  during  imaging  in  radiotherapy,  are 
reviewed. 
DOSE OPTIMISATION DURING PORTAL IMAGING IN 
RADIATION THERAPY 
It has been concluded from early studies that portal 
films  are  essential  for  accurate  delivery  of  radiation 
therapy,  and  frequent  filming  may  be  required  to 
decrease the frequency of localisation and field design 
error  [2].  Portal  images  are  acquired  either  by  single 
exposure technique or by double exposure technique. In 
single exposure technique, the treatment beam is used to 
image the region to be treated when adequate landmarks 
are available for verification within this region. The dose 
delivered during this single exposure portal imaging is 
usually adjusted from the treatment dose and this does 
not  deliver  dose  to  normal  tissues.  When  adequate 
landmarks are not available within the treatment region, 
a  double  exposure  technique  is  used.  In  this  double 
exposure technique, a field at least 5cm larger than the 
area to be treated is also imaged in addition to the region 
to be treated. This results in delivering dose outside the 
tumour  volume  and  thus  increases  the  probability  of 
stochastic effect. The risk of cancer induction is additive 
and  the  concomitant  dose  from  the  double  exposure 
portal images adds to the dose received by the patient 
due to leakage and scatter radiation [6]. Several studies 
have  been  performed  to  increase  the  image  quality 
during portal imaging and thus reduce the dose during 
portal imaging. Crooks and  Fallore have estimated the 
dose during the portal imaging with three different films 
viz. CEA TLF, CEA TVS and Kodak EC-L films and the 
dose during portal imaging is estimated as 1.2 cGy, 15.9 
cGy  and  1.5  cGy  for  the  CEA  TLF,  CEA  TVS  and 
Kodak  EC-L  films,  respectively  [7].  The  authors  have 
concluded  that  the  CEA  TVS  film  could  be  used  for 
single exposure, where it could be taken out during the 
exposure (treatment) and CEA TLF or the Kodak EC-L 
films for double exposure as they require very low dose 
to get optimally-exposed images. 
A  few  authors  have  tried  portal  imaging  with 
computed  radiography  (CR),  a  non-film-based  system, 
used to obtain high quality portal images. In this system, 
the  film  is  replaced  with  a  photostimulable  phosphor 
plate [8]. In addition to the advantages of digital imaging, 
this technique produces excellent images with radiation 
exposures of 1 and 2 monitor units (MU) only. The use 
of  CR  for  portal  imaging  is  also  being  tried  in  the 
author’s institute where PSP plates are used with a CR 
reader  for  obtaining  portal  images.  Single  and  double 
exposure  images  obtained  with  1 MU/exposure  are 
shown in Figure 1a and Figure 1b, respectively. 
Jaffray et al have suggested a method to reduce the 
dose  during  double  exposure  and  enhance  the  image 
quality by using a dual-beam system consisting of a kV 
X-ray tube  mounted on the  gantry of a  medical linear 
accelerator thus mixing low- and high-energy beams for 
double  exposure  technique  [9].  Both  the  kV  and  MV 
images are collected with a fluoroscopic imaging system 
that  uses  a  low-noise  CCD  camera  to  accumulate  the 
light emitted from a phosphor screen. The authors have 
concluded  that  the  quality  of  the  dual-beam  image  is 
similar to the prescription (simulation) image, contains a 
larger anatomical region, and delivers a lower integral 
dose to the patient. 
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Radiation  dose  delivered  during  double  exposure 
portal  imaging  for  pediatric  radiotherapy  has  been 
evaluated  by  Kudchadker  et  al  by  conducting  a 
retrospective  review  of  the  port  film  dose  for  56 
consecutive pediatric patients who underwent definitive 
radiation  therapy  [4]. The  mean  total  port  dose  varied 
from a maximum of 46 cGy for the brain to a minimum 
of 17 cGy for the thorax. The mean total port dose as a 
percentage of prescribed dose was less than 1.25% for all 
locations in this study. However, most of the port dose is 
a result of the open-field dose from the double-exposure 
technique. Kudchadker et al suggest that care should be 
exercised while exposing port films of pediatric patients 
to minimise both the number of films and the radiation 
dose  without  compromising  the  quality  of  treatment 
delivery.  The  specific  suggestion  of  the  authors  is  to 
minimise  the  number  of  monitor  units  used  to  image 
regions outside the treatment field to reduce the risk of 
development of secondary neoplasms. 
Development of Electronic Portal Imaging devices and 
Cone Beam CT systems 
The  requirement  for  better  visualisation  of  MV 
images  and  enhanced  image  quality  for  verification  of 
setup  for  conformal  radiotherapy  has  led  to  the 
development of online electronic portal imaging devices, 
which have replaced the conventional film-based portal 
imaging [10].  The main advantage of this type of portal 
imaging over film is the immediate (online) availability 
of  images  that  enables  verification  and  correction  of 
patient setup before treatment. 
The  availability  of  digital  images  from  the  EPID 
makes  image  processing,  contrast  enhancement  and 
automatic comparison  with planning images (simulator 
images or DRR) possible. The development of the EPID 
has undergone several significant changes starting from 
video camera- and mirror-based EPIDs, to the recent a-Si 
based flat panel EPIDs. The construction, development 
and  the  physics  of  these  portal  imaging  devices  have 
been  discussed  in  several  publications  [1,  3,  11].  The 
other major advantage with the a-Si flat panel EPIDs is 
the considerable low MUs required to produce the portal 
images. A primus linear accelerator fitted with an a-Si 
flat panel portal imaging system is shown in Figure 2. A 
portal image acquisition mode has also been developed 
for  the  PortalVision™  that  allows  one  to  take  portal 
images  with  reduced  dose  while  keeping  good  image 
quality [12]. Moreover, the introduction of the a-Si flat 
panel  imaging  devices  and  the  interest  to  have  3D 
verification images have led to the development of cone 
beam  CT-based  Image  Guided  Radiotherapy  system 
(IGRT). The availability of full volumetric information 
of the patient anatomy with single rotation of the source 
and the detector has led to the development and clinical 
implementation of both the MV and kV cone beam CT 
for image guided precision radiotherapy. MV cone beam 
CT has been developed using the treatment beam and the 
EPID [13-15]. In order to increase the image quality kV 
cone beam CT has been developed with a kV X-ray tube 
and an a-Si flat panel detector fixed at 90
o to the MV 
source  [5,  16].  An  Elekta  linear  accelerator  with 
integrated kV CBCT system is shown in Figure 3. The 
imaging performance of both kV and MV cone beam CT 
has been compared [17]. 
Dose during MV and kV CBCT 
Although the clinical use of cone beam CT in image 
guidance has improved the accuracy in patient setup and 
radiation delivery, the dose delivered during the image 
guidance is of significant concern, as the volume of the 
tissue  irradiated  is  much  more  than  the  volume  to  be 
treated  and  several  times  higher  than  the  volume 
irradiated during the double exposure technique of portal 
imaging.  Moreover,  repeated  imaging  using  the  cone 
beam CT through several fractions during the course of 
the treatment is likely to result in a significant dose to 
normal  tissues  that  can  increase  the  probability  of 
stochastic effect. 
MV cone beam CT 
MV cone beam CT is simple to use, as it does not 
require  additional  hardware  except  for  a-Si  flat  panel 
detector  with  high  detection  quantum  efficiency. 
However, relatively lesser image quality compared to kV 
cone beam CT images and radiation dose during the cone 
beam  CT  are  of  great  concern.  Initial  attempts  to 
generate MV cone beam CT with about 90
o projections  
resulted in a central dose of about 90 cGy [13]. As one 
cannot employ full-field imaging on a regular basis with 
the MV cone beam CT doses mentioned above, attempt 
has been made to image the region of interest (GTV/PTV) 
using conformal beams and to improve the image quality 
with  a-Si  flat-panel  EPID  that  has  higher  detective 
quantum efficiency [15]. The dose during the MV cone 
beam CT was reduced by Seppi et al by developing an 
 
Figure 3  kV X-ray source and flat panel detector fixed at 90° to 
treatment beam of a linear accelerator for image 
guidance with kV cone beam CT. P Ravindran. Biomed Imaging Interv J 2007; 3(2):e23    5 
    This page number is not 
    for citation purpose 
 
image  receptor  that  uses  a  flat-panel  imaging  system 
consisting of a conventional flat-panel sensor attached to 
a thick CsI scintillator [18]. The scintillator consists of 
individual CsI crystals 8 mm thick and 0.38 mm by 0.38 
mm pitch. With this, projection images could be obtained 
with one accelerator pulse delivering as little as 0.023 
cGy  per  image.  They  could  generate  MV  CT  images 
with soft tissue contrast with irradiations as small as 16 
cGy. Further dose reduction during MV cone beam CT 
has been achieved by windowing the dose-pulse rate of 6 
MV Primus accelerator beam to expose an a-Si flat panel 
by using only 0.02 to 0.08 MUs per image and produce 
low-noise 3D MV cone beam CT images without pulsing 
artifacts with a total delivered dose that ranged from 5 to 
15 cGy [19]. 
kV cone beam CT 
Imaging  using  a  kV  beam  is  superior  to  the  MV 
imaging as photoelectric interaction, which depends on 
the atomic number, is dominant in this energy range and 
hence  gives  better  subject  contrast  resulting  in  clear 
differentiation  between  bone  and  tissue.  Although  the 
dose  to  the  patient  due  to  a  kV  image-guided 
radiotherapy is small compared to that of the MV image 
guidance, a large volume of the normal tissue is involved 
in the cone beam CT imaging and the repeated use of this 
modality  for  image  guidance  on  a  daily  basis  may 
contribute  significant  dose  to  normal  tissue.  The  dose 
during a kV cone beam CT and the dose at the centre and 
surface of the body phantom have been estimated as 1.6 
cGy and 2.3 cGy for a typical imaging protocol using full 
rotation scan, with a technique setting of 120 kVp and 
660 mAs [20]. Similarly, the dose to the surface of the 
eyes during a kV cone beam CT head scan and the dose 
to the surface of the breast and the contra-lateral breast 
during  a  kV  cone  beam  CT  breast  scan  have  been 
estimated with humanoid phantoms, and methods have 
also been suggested to reduce the dose during a kV cone 
beam CT [21]. Using a lesser number of projections to 
reduce the dose and the impact on the image quality has 
also been studied [20]. The possibility of achieving an 
ultra-low  dose  of  about  1  mGy  per  scan  has  been 
reported  by  attempting  to  generate  low  exposure 
volumetric  X  ray  CT  by  reducing  the  number  of 
exposures (projections) [22]. 
CONCLUSION 
Imaging during radiation therapy  has a  significant 
role as it reduces the setup error and avoids geographical 
miss. Portal imaging and 3D image guided radiotherapy 
with  cone  beam  CT  have  increased  the  accuracy  of 
treatment  delivery  considerably.  However,  one  should 
remember that a significant amount of normal tissue is 
irradiated  in  this  process  and  could  increase  the 
probability of stochastic effect. Hence, it is necessary to 
develop  protocols  to  optimally  use  the  imaging 
techniques  for  treatment  delivery  in  radiotherapy  that 
could significantly reduce the risk of stochastic effect. 
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